AAAAAA
Results:
1-15
|
Results: 15
Authors:
Michel, ML
Loirat, D
Citation: Ml. Michel et D. Loirat, DNA vaccines for prophylactic or therapeutic immunization against hepatitis B, INTERVIROLO, 44(2-3), 2001, pp. 78-87
Authors:
Michel, ML
Pol, S
Brechot, C
Tiollais, P
Citation: Ml. Michel et al., Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future, VACCINE, 19(17-19), 2001, pp. 2395-2399
Authors:
Le Borgne, S
Michel, ML
Camugli, S
Corre, B
Le Grand, R
Riviere, Y
Citation: S. Le Borgne et al., Expansion of HBV-specific memory CTL primed by dual HIV/HBV genetic immunization during SHIV primary infection in rhesus macaques, VACCINE, 19(17-19), 2001, pp. 2485-2495
Authors:
Pol, S
Nalpas, B
Driss, F
Michel, ML
Tiollais, P
Denis, J
Brechot, C
Citation: S. Pol et al., Efficacy and limitations of a specific immunotherapy in chronic hepatitis B, J HEPATOL, 34(6), 2001, pp. 917-921
Authors:
Malanchere-Bres, E
Payette, PJ
Mancini, M
Tiollais, P
Davis, HL
Michel, ML
Citation: E. Malanchere-bres et al., CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-Transgenic mice, J VIROLOGY, 75(14), 2001, pp. 6482-6491
Authors:
Firat, H
Tourdot, S
Ureta-Vidal, A
Scardino, A
Suhrbier, A
Buseyne, F
Riviere, Y
Danos, O
Michel, ML
Kosmatopoulos, K
Lemonnier, FA
Citation: H. Firat et al., Design of a polyepitope construct for the induction of HLA-A0201-restricted HIV 1-specific CTL responses using HLA-A0201 transgenic, H-2 class IKO mice, EUR J IMMUN, 31(10), 2001, pp. 3064-3074
Authors:
Pol, S
Michel, ML
Brechot, C
Citation: S. Pol et al., Immune therapy of hepatitis B virus chronic infection, HEPATOLOGY, 31(2), 2000, pp. 548-549
Authors:
Le Borgne, S
Le Grand, R
Michel, ML
Vaslin, B
Boson, B
Janvier, G
Aubertin, AM
Dormont, D
Riviere, Y
Citation: S. Le Borgne et al., Immune responses following simian/human immunodeficiency virus (SHIV) challenge of rhesus macaques after human immunodeficiency virus (HIV)-1 third variable domain (V3) loop-based genetic immunization, J MED PRIM, 29(6), 2000, pp. 371-386
Authors:
Loirat, D
Lemonnier, FA
Michel, ML
Citation: D. Loirat et al., Multiepitopic HLA-A0201-restricted immune response against hepatitis B surface antigen after DNA-based immunization, J IMMUNOL, 165(8), 2000, pp. 4748-4755
Authors:
Pol, S
Michel, ML
Brechot, C
Citation: S. Pol et al., Immune therapy of hepatitis B virus (HBV) chronic infection. European experience, ACT GASTR B, 63(2), 2000, pp. 194-196
Authors:
Tiollais, P
Michel, ML
Citation: P. Tiollais et Ml. Michel, Genetic vaccination. Prospects for prevention and treatment of hepatitis B, CR AC S III, 322(11), 1999, pp. 979-981
Authors:
Hui, JY
Mancini, M
Li, GD
Wang, Y
Tiollais, P
Michel, ML
Citation: Jy. Hui et al., Immunization with a plasmid encoding a modified hepatitis B surface antigen carrying the receptor binding site for hepatocytes, VACCINE, 17(13-14), 1999, pp. 1711-1718
Authors:
Loirat, D
Li, ZL
Mancini, M
Tiollais, P
Paulin, D
Michel, ML
Citation: D. Loirat et al., Muscle-specific expression of hepatitis B surface antigen: No effect on DNA-raised immune responses, VIROLOGY, 260(1), 1999, pp. 74-83
Authors:
Couillin, I
Pol, S
Mancini, M
Driss, F
Brechot, C
Tiollais, P
Michel, ML
Citation: I. Couillin et al., Specific vaccine therapy in chronic hepatitis B: Induction of T cell proliferative responses specific for envelope antigens, J INFEC DIS, 180(1), 1999, pp. 15-26
Authors:
Firat, H
Garcia-Pons, F
Tourdot, S
Pascolo, S
Scardino, A
Garcia, Z
Michel, ML
Jack, RW
Jung, G
Kosmatopoulos, K
Mateo, L
Suhrbier, A
Lemonnier, FA
Langlade-Demoyen, P
Citation: H. Firat et al., H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies, EUR J IMMUN, 29(10), 1999, pp. 3112-3121
Risultati:
1-15
|